Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 10,010
+480 (5.04%)
Nov 20, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 221.64 billion as of November 19, 2025. Its market cap has decreased by -26.97% in one year.
Market Cap
221.64B
Enterprise Value
183.60B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10,010.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 221.64B, an increase of 38.32%. That is a compound annual growth rate of 6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 221.64B | -7.58% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2.52T | 1,470.89% |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 626.19T |
| SK hynix | 388.01T |
| LG Energy Solution | 102.38T |
| Samsung Biologics | 86.90T |
| Hyundai Motor Company | 57.57T |
| HD Hyundai Heavy Industries | 50.96T |
| Doosan Enerbility | 47.65T |
| Hanwha Aerospace | 47.38T |